US FDA examined 22 cases of cancers in CAR-T probe -officials
By Michael Erman and Deena Beasley NEW YORK (Reuters) -The U.S. Food and Drug Administration has been looking into 22 cases of T-cell cancers that occurred ...
Source: saltwire.com
Page 29 - Michael Erman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Erman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Erman Today - Breaking & Trending Today
Drugmakers Plot Way Into Obesity Market With Deals and Development
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...
Source: medscape.com
Drugmakers plot way into obesity market with deals and development
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly. Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San Francisco this week.
Source: yahoo.com
Weight loss drug windfall attracts pharma companies
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's...
Source: marketscreener.com
Pfizer to remain aggressive on obesity market after setback
By Michael Erman NEW YORK (Reuters) -Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile ...
Source: saltwire.com